Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective decrease in Leu8-negative T cell subpopulations following treatment with recombinant interferon-alpha 2a

O Martínez-Maza1, R A Figlin, J V Giorgi

  • 1Department of Microbiology, University of California, Los Angeles School of Medicine 90024.

Cellular Immunology
|November 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India.

AIDS research and treatment·2012
Same author

Continuing medical education on antiretroviral therapy in HIV/AIDS in India: needs assessment and impact on clinicians and allied health personnel.

The National medical journal of India·2010
Same author

Preparation of cells and reagents for flow cytometry.

Current protocols in immunology·2008
Same author

Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Idiopathic CD4+ T cell lymphocytopenia evolving to monoclonal immunoglobulins and progressive renal damage responsive to IL-2 therapy.

Clinical immunology (Orlando, Fla.)·2001
Same author

Simultaneous flow cytometric measurement of viability and lymphocyte subset proliferation.

Journal of immunological methods·2001
Same journal

Retraction notice to "Myeloid-derived suppressor cells accumulate in the liver site after sepsis to induce immunosuppression" Cellular Immunology 279 (2012) 12-20.

Cellular immunology·2026
Same journal

The uptake, intracellular trafficking and recycling of FcRn-blocking therapeutics in human endothelial cells in vitro.

Cellular immunology·2026
Same journal

Exosome-mediated immune modulation in rheumatoid arthritis and its role in synovial inflammation and autoimmune amplification.

Cellular immunology·2026
Same journal

Persistent CD4<sup>+</sup> T cell hyporesponsiveness during recovery from prolonged symptomatic SARS-CoV-2 infection.

Cellular immunology·2026
Same journal

Deficit in blood MAIT cells, altered cytokines and T cell dynamics in patients with coronary artery disease.

Cellular immunology·2026
Same journal

The circ_0003692-miR-1197-TLR4 axis: A key regulator in rheumatoid arthritis proliferation and inflammation.

Cellular immunology·2026
See all related articles

Recombinant human interferon-alpha 2a (rIFN-alpha 2a) treatment in renal cell adenocarcinoma patients reduced total T cells but increased spontaneous immunoglobulin secretion. Leu8-negative T cells decreased more significantly in CD4 and CD8 populations.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Interferon-alpha (IFN-alpha) is a cytokine with immunomodulatory and anti-tumor properties.
  • Its effects on T cell subpopulations in renal cell adenocarcinoma (RCC) patients require further elucidation.

Purpose of the Study:

  • To investigate the in vivo impact of recombinant human IFN-alpha 2a (rIFN-alpha 2a) on T cell distribution in RCC patients.
  • To assess changes in immune status parameters during rIFN-alpha 2a therapy.

Main Methods:

  • Twenty-one RCC patients received rIFN-alpha 2a treatment.
  • Two-color flow cytometry was used to analyze T cell subpopulations (CD4, CD8, Leu8 expression).
  • Measurements included total T cell counts, mitogen proliferation, and spontaneous immunoglobulin secretion.

Related Experiment Videos

Main Results:

  • Total T cell numbers decreased significantly, reaching 54% of pretreatment values after 4 weeks.
  • The CD4/CD8 ratio remained largely unchanged.
  • A notable decrease in Leu8-negative T cells within both CD4 and CD8 populations was observed, alongside an increase in spontaneous immunoglobulin-secreting cells.

Conclusions:

  • In vivo rIFN-alpha 2a treatment alters T cell distribution in RCC patients, specifically reducing Leu8-negative subsets.
  • The observed increase in immunoglobulin secretion suggests a potential impact on B cell function or antibody production.
  • These findings contribute to understanding the immunomodulatory effects of IFN-alpha in cancer therapy.